Patients taking Eli Lilly & Co.’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity. It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback